Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
23.49 USD | -0.29% | -0.88% | -37.27% |
Feb. 28 | UBS Adjusts AdaptHealth Price Target to $13 From $9, Maintains Buy Rating | MT |
Feb. 28 | Deutsche Bank Adjusts AdaptHealth Price Target to $10 From $8, Maintains Hold Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration- Stock
- Equities
- Stock DFB Healthcare Acquisitions Corp. - Nasdaq
- News DFB Healthcare Acquisitions Corp.
- AdaptHealth Swings to Profit in Q3, Revenue Climbs; Raises 2021 Revenue Guidance, Provides 2022 Guidance